[64Cu]Cu-NOTA-EV-F(ab')2

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name[64Cu]Cu-NOTA-EV-F(ab')2

Drug Alias Name64Cu-NOTA-EV-F(ab')2[64Cu]Cu-NOTA-EV-F(ab')2[64Cu]-NOTA-EV-F(ab')2

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionNectin-4 binders

TargetsNectin-4

Therapy Area/IndicationsUrinary Bladder NeoplasmsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesThe First Affiliated Hospital Of Beijing University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing University

Inactive CompaniesN/A

Active IndicationsUrinary Bladder NeoplasmsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A